MXPA05011840A - Procedimiento para cristalizar sales de guanidinio. - Google Patents

Procedimiento para cristalizar sales de guanidinio.

Info

Publication number
MXPA05011840A
MXPA05011840A MXPA05011840A MXPA05011840A MXPA05011840A MX PA05011840 A MXPA05011840 A MX PA05011840A MX PA05011840 A MXPA05011840 A MX PA05011840A MX PA05011840 A MXPA05011840 A MX PA05011840A MX PA05011840 A MXPA05011840 A MX PA05011840A
Authority
MX
Mexico
Prior art keywords
crystallizing
guanidinium salts
salts
guanidinium
formula
Prior art date
Application number
MXPA05011840A
Other languages
English (en)
Inventor
Ricky Lippert
Original Assignee
Merck Patent Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck Patent Gmbh filed Critical Merck Patent Gmbh
Publication of MXPA05011840A publication Critical patent/MXPA05011840A/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/30—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
    • C07D207/32—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • C07D207/33—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms with substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • C07D207/337—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C277/00—Preparation of guanidine or its derivatives, i.e. compounds containing the group, the singly-bound nitrogen atoms not being part of nitro or nitroso groups
    • C07C277/08—Preparation of guanidine or its derivatives, i.e. compounds containing the group, the singly-bound nitrogen atoms not being part of nitro or nitroso groups of substituted guanidines
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C317/00—Sulfones; Sulfoxides
    • C07C317/44—Sulfones; Sulfoxides having sulfone or sulfoxide groups and carboxyl groups bound to the same carbon skeleton
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/02—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
    • C07D307/34—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D307/56—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D307/68—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Peptides Or Proteins (AREA)
  • Pyrrole Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

La invencion se refiere a un procedimiento para cristalizar los compuestos de la formula I o sus sales por adicion de acidos (ver formula I), donde R1, R2 y R3 presentan el significado indicado en la reivindicacion 1.
MXPA05011840A 2003-05-06 2004-04-10 Procedimiento para cristalizar sales de guanidinio. MXPA05011840A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE10320016 2003-05-06
PCT/EP2004/003838 WO2004099125A1 (de) 2003-05-06 2004-04-10 Verfahren zur kristallisation von guanidinium-salzen

Publications (1)

Publication Number Publication Date
MXPA05011840A true MXPA05011840A (es) 2006-01-26

Family

ID=33426672

Family Applications (1)

Application Number Title Priority Date Filing Date
MXPA05011840A MXPA05011840A (es) 2003-05-06 2004-04-10 Procedimiento para cristalizar sales de guanidinio.

Country Status (19)

Country Link
US (1) US7629493B2 (es)
EP (1) EP1620394B1 (es)
JP (1) JP2006525247A (es)
KR (1) KR20060015580A (es)
CN (1) CN1784381A (es)
AR (1) AR044252A1 (es)
AT (1) ATE404533T1 (es)
AU (1) AU2004235886B2 (es)
BR (1) BRPI0410022A (es)
CA (1) CA2524718A1 (es)
DE (1) DE502004007841D1 (es)
DK (1) DK1620394T3 (es)
ES (1) ES2310725T3 (es)
MX (1) MXPA05011840A (es)
PL (1) PL1620394T3 (es)
PT (1) PT1620394E (es)
RU (1) RU2374224C2 (es)
WO (1) WO2004099125A1 (es)
ZA (1) ZA200509867B (es)

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3975533A (en) * 1970-04-29 1976-08-17 Shell Oil Company Therapeutic agents
US4113776A (en) * 1976-04-15 1978-09-12 Hoffmann-La Roche Inc. 1-(2-Aminoethyl)-3-(2,6-dihalophenyl)guanidines
JPS61129159A (ja) * 1984-11-28 1986-06-17 Nippon Zeon Co Ltd 保護化アミノ酸アミド化合物の精製法
ES2097409T3 (es) * 1992-09-22 1997-04-01 Hoechst Ag Benzoilguanidinas, procedimiento para su preparacion, asi como su empleo como antiarritmicos.
IL109570A0 (en) * 1993-05-17 1994-08-26 Fujisawa Pharmaceutical Co Guanidine derivatives, pharmaceutical compositions containing the same and processes for the preparation thereof
DE4328352A1 (de) * 1993-08-24 1995-03-02 Hoechst Ag Substituierte N,N'-Di-benzoylguanidine, Verfahren zu ihrer Herstellung, ihre Verwendung als Medikament oder Diagnostikum sowie sie enthaltendes Medikament
DE4430916A1 (de) * 1994-08-31 1996-03-07 Merck Patent Gmbh Alkyl-benzoylguanidin-Derivate
DE4430861A1 (de) * 1994-08-31 1996-03-07 Merck Patent Gmbh Heterocyclyl-benzoylguanidine
DE19529612A1 (de) 1995-08-11 1997-02-13 Merck Patent Gmbh Sulfonyl- oder Sulfinyl-benzoylguanidin-Derivate
DE19737224A1 (de) * 1997-08-27 1999-03-18 Hoechst Marion Roussel De Gmbh Pharmazeutisches Kombinationspräparat aus einem Inhibitor des Natrium-Wasserstoff-Austauschers und einem Arzneimittel zur Behandlung von Herz-Kreislauferkrankungen
DE19738604A1 (de) * 1997-09-04 1999-03-11 Hoechst Marion Roussel De Gmbh Die Verwendung von Hemmern des Natrium-Wasserstoff-Austauschers zur Herstellung eines Medikaments zur Verminderung der Giftigkeit cardiotoxischer Stoffe
US6147098A (en) * 1998-05-11 2000-11-14 Novo Nordisk A/S Substituted guanidines and diaminonitroethenes, their preparation and use
DE19951418A1 (de) * 1999-10-26 2001-05-03 Merck Patent Gmbh Verfahren zur Herstellung von N-(4,5-Bismethansulfonyl-2-methyl-benzoyl) -guanidin, Hydrochlorid

Also Published As

Publication number Publication date
CA2524718A1 (en) 2004-11-18
RU2374224C2 (ru) 2009-11-27
PT1620394E (pt) 2008-11-24
ES2310725T3 (es) 2009-01-16
JP2006525247A (ja) 2006-11-09
KR20060015580A (ko) 2006-02-17
BRPI0410022A (pt) 2006-04-25
EP1620394A1 (de) 2006-02-01
ZA200509867B (en) 2006-12-27
AR044252A1 (es) 2005-09-07
PL1620394T3 (pl) 2008-12-31
DE502004007841D1 (de) 2008-09-25
US7629493B2 (en) 2009-12-08
US20070055064A1 (en) 2007-03-08
DK1620394T3 (da) 2008-11-24
CN1784381A (zh) 2006-06-07
AU2004235886B2 (en) 2010-07-01
EP1620394B1 (de) 2008-08-13
WO2004099125A1 (de) 2004-11-18
ATE404533T1 (de) 2008-08-15
AU2004235886A1 (en) 2004-11-18

Similar Documents

Publication Publication Date Title
HK1087022A1 (en) Dpp-iv inhibitors
MXPA03011039A (es) Nuevos compuestos heterociclicos, su preparacion y uso como medicamentos, particularmente como agentes anti-bacterianos.
AP1614A (en) New heterocyclic compounds, their preparation and their use as medicaments, in particular as anti-bacterial agents.
UA81568C2 (en) Benzoyl-substituted phenylalanine amides, methods and intermediate products for the production thereof, herbicidal composition and method for controlling undesired plants
WO2003093269A3 (de) Substituierte pyrazolo-pyrimidin-4-one
WO2001072702A3 (en) Amidino compounds useful as nitric oxide synthase inhibitors
WO2004062613A3 (en) Hiv integrase inhibitors
EA017861B9 (ru) Способ получения 4-оксохинолинового соединения
SI1572699T1 (sl) Kristalne soli cefdinira
PL1685142T3 (pl) Pochodne kwasu fosfinowego, inhibitory beta-sekterazy do leczenia choroby Alzheimera
WO2005058885A3 (en) Piperidine derivatives and their use as glycine transporter inhibitors
WO2004035800A3 (en) Intermediate cefdinir salts
MY140164A (en) Pyridopyrimidinone compounds, method for production thereof and medicaments comprising the same
RS20060239A (en) Arylalkylcarbamate derivatives, preparation method thereof and use of same in therapeutics
TW200719889A (en) Amino acid derivatives
UA96149C2 (en) Method for producing 4-oxoquinoline compound
ID26210A (id) Proses pemurnian turunan sefalosporin
MXPA04009421A (es) Compuestos de tiazol-2-ilimina como inhibidores de la pde-7.
WO2002088125A3 (de) Triazolopyrimidine mit fungizider wirkung
MXPA05010398A (es) Nuevo metodo para la sintesis del acido (2s)-indolin-2-carboxilico y aplicacion de mismo en la sintesis del perindopril.
TNSN06233A1 (en) 7-phenylamino-4-quinolone-3-carboxylic acid derivatives, methods for production and use thereof as medicaments
MXPA05011840A (es) Procedimiento para cristalizar sales de guanidinio.
EP1571144A4 (en) HYDROXYALKYLATED CYCLIC DEDIAMINE COMPOUND
WO2007057767A3 (en) Amino acid derivatives
TWI265151B (en) Method of purifying niobium compound and/or tantalum compound

Legal Events

Date Code Title Description
FG Grant or registration